VRBPAC endorsed mRNA-1010 for adults 50-64 and ≥65 years, unanimously concluding benefits outweighed risks, supporting a late-stage regulatory path toward potential first mRNA seasonal influenza ...
No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher adverse events related to the vaccine reportedSOUTH SAN ...
No significant difference in the risk for serious infections in patients with psoriasis was noted among most systemic ...
Morning Overview on MSN
The FDA approved a cell therapy to curb a deadly complication of stem-cell transplants
Children who survive a stem-cell transplant only to watch their own donor cells attack their organs now have a ...
Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 ...
Explore how the DSS employs spy technology for unlawful monitoring and secret arrests without trial in Nigeria's national security efforts.
"What makes our analysis notable is that by focusing on non-caloric comparators, we better isolated the direct physiological ...
OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, Listeria-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results